Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
The global Glucagon market was valued at US$ 524 million in 2020 and is expected to reach US$ 793.2 million by the end of 2029, growing at a CAGR of 6.1% during 2021-2029.
This report focuses on Glucagon volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Glucagon market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Glucagon Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2029. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Inject Glucagon
Nasal Glucagon
Segment by Application
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
1 Glucagon Market Overview
1.1 Product Overview and Scope of Glucagon
1.2 Glucagon Segment by Type
1.2.1 Global Glucagon Sales Growth Rate Comparison by Type (2021-2029)
1.2.2 Inject Glucagon
1.2.3 Nasal Glucagon
1.3 Glucagon Segment by Application
1.3.1 Global Glucagon Sales Comparison by Application: (2021-2029)
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 Global Glucagon Market Size Estimates and Forecasts
1.4.1 Global Glucagon Revenue 2016-2029
1.4.2 Global Glucagon Sales 2016-2029
1.4.3 Glucagon Market Size by Region: 2016 Versus 2021 Versus 2029
2 Glucagon Market Competition by Manufacturers
2.1 Global Glucagon Sales Market Share by Manufacturers (2016-2021)
2.2 Global Glucagon Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Glucagon Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Glucagon Manufacturing Sites, Area Served, Product Type
2.5 Glucagon Market Competitive Situation and Trends
2.5.1 Glucagon Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Glucagon Players Market Share by Revenue
2.5.3 Global Glucagon Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glucagon Retrospective Market Scenario by Region
3.1 Global Glucagon Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Glucagon Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Glucagon Market Facts & Figures by Country
3.3.1 North America Glucagon Sales by Country
3.3.2 North America Glucagon Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Glucagon Market Facts & Figures by Country
3.4.1 Europe Glucagon Sales by Country
3.4.2 Europe Glucagon Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Glucagon Market Facts & Figures by Region
3.5.1 Asia Pacific Glucagon Sales by Region
3.5.2 Asia Pacific Glucagon Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Glucagon Market Facts & Figures by Country
3.6.1 Latin America Glucagon Sales by Country
3.6.2 Latin America Glucagon Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Glucagon Market Facts & Figures by Country
3.7.1 Middle East and Africa Glucagon Sales by Country
3.7.2 Middle East and Africa Glucagon Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Glucagon Historic Market Analysis by Type
4.1 Global Glucagon Sales Market Share by Type (2016-2021)
4.2 Global Glucagon Revenue Market Share by Type (2016-2021)
4.3 Global Glucagon Price by Type (2016-2021)
5 Global Glucagon Historic Market Analysis by Application
5.1 Global Glucagon Sales Market Share by Application (2016-2021)
5.2 Global Glucagon Revenue Market Share by Application (2016-2021)
5.3 Global Glucagon Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Glucagon Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novo Nordisk Glucagon Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Glucagon Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Eli Lilly Glucagon Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Corporation Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Glucagon Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Fresenius Kabi Glucagon Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Torrent Labs
6.4.1 Torrent Labs Corporation Information
6.4.2 Torrent Labs Description and Business Overview
6.4.3 Torrent Labs Glucagon Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Torrent Labs Glucagon Product Portfolio
6.4.5 Torrent Labs Recent Developments/Updates
6.5 Taj Pharmaceuticals
6.5.1 Taj Pharmaceuticals Corporation Information
6.5.2 Taj Pharmaceuticals Description and Business Overview
6.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Taj Pharmaceuticals Glucagon Product Portfolio
6.5.5 Taj Pharmaceuticals Recent Developments/Updates
6.6 Xeris Pharmaceuticals
6.6.1 Xeris Pharmaceuticals Corporation Information
6.6.2 Xeris Pharmaceuticals Description and Business Overview
6.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Xeris Pharmaceuticals Glucagon Product Portfolio
6.6.5 Xeris Pharmaceuticals Recent Developments/Updates
7 Glucagon Manufacturing Cost Analysis
7.1 Glucagon Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Glucagon
7.4 Glucagon Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Glucagon Distributors List
8.3 Glucagon Customers
9 Glucagon Market Dynamics
9.1 Glucagon Industry Trends
9.2 Glucagon Growth Drivers
9.3 Glucagon Market Challenges
9.4 Glucagon Market Restraints
10 Global Market Forecast
10.1 Glucagon Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Glucagon by Type (2022-2029)
10.1.2 Global Forecasted Revenue of Glucagon by Type (2022-2029)
10.2 Glucagon Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Glucagon by Application (2022-2029)
10.2.2 Global Forecasted Revenue of Glucagon by Application (2022-2029)
10.3 Glucagon Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Glucagon by Region (2022-2029)
10.3.2 Global Forecasted Revenue of Glucagon by Region (2022-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Glucagon Sales (K MT) Growth Rate Comparison by Type (2021-2029)
Table 2. Global Glucagon Sales (K MT) Comparison by Application (2021-2029)
Table 3. Global Glucagon Market Size by Region (US$ Million) (2016 VS 2021 VS 2029)
Table 4. Key Manufacturers Glucagon Covered in This Study
Table 5. Global Glucagon Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Glucagon Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Glucagon Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Glucagon Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Glucagon Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Glucagon Manufacturing Sites and Area Served
Table 11. Manufacturers Glucagon Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Glucagon by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Glucagon Sales by Region (2016-2021) & (K MT)
Table 16. Global Glucagon Sales Market Share by Region (2016-2021)
Table 17. Global Glucagon Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Glucagon Sales by Country (2016-2021) & (K MT)
Table 19. North America Glucagon Sales Market Share by Country (2016-2021)
Table 20. North America Glucagon Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Glucagon Revenue Market Share by Country (2016-2021)
Table 22. Europe Glucagon Sales by Country (2016-2021) & (K MT)
Table 23. Europe Glucagon Sales Market Share by Country (2016-2021)
Table 24. Europe Glucagon Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Glucagon Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Glucagon Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Glucagon Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Glucagon Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Glucagon Revenue Market Share by Region (2016-2021)
Table 30. Latin America Glucagon Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Glucagon Sales Market Share by Country (2016-2021)
Table 32. Latin America Glucagon Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Glucagon Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Glucagon Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Glucagon Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Glucagon Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Glucagon Revenue Market Share by Country (2016-2021)
Table 38. Global Glucagon Sales (K MT) by Type (2016-2021)
Table 39. Global Glucagon Sales Market Share by Type (2016-2021)
Table 40. Global Glucagon Revenue (Million US$) by Type (2016-2021)
Table 41. Global Glucagon Revenue Share by Type (2016-2021)
Table 42. Global Glucagon Price (USD/MT) by Type (2016-2021)
Table 43. Global Glucagon Sales (K MT) by Application (2016-2021)
Table 44. Global Glucagon Sales Market Share by Application (2016-2021)
Table 45. Global Glucagon Revenue (Million US$) by Application (2016-2021)
Table 46. Global Glucagon Revenue Share by Application (2016-2021)
Table 47. Global Glucagon Price (USD/MT) by Application (2016-2021)
Table 48. Novo Nordisk Corporation Information
Table 49. Novo Nordisk Description and Business Overview
Table 50. Novo Nordisk Glucagon Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Novo Nordisk Glucagon Product
Table 52. Novo Nordisk Recent Developments/Updates
Table 53. Eli Lilly Corporation Information
Table 54. Eli Lilly Description and Business Overview
Table 55. Eli Lilly Glucagon Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Eli Lilly Glucagon Product
Table 57. Eli Lilly Recent Developments/Updates
Table 58. Fresenius Kabi Corporation Information
Table 59. Fresenius Kabi Description and Business Overview
Table 60. Fresenius Kabi Glucagon Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Fresenius Kabi Glucagon Product
Table 62. Fresenius Kabi Recent Developments/Updates
Table 63. Torrent Labs Corporation Information
Table 64. Torrent Labs Description and Business Overview
Table 65. Torrent Labs Glucagon Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Torrent Labs Glucagon Product
Table 67. Torrent Labs Recent Developments/Updates
Table 68. Taj Pharmaceuticals Corporation Information
Table 69. Taj Pharmaceuticals Description and Business Overview
Table 70. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Taj Pharmaceuticals Glucagon Product
Table 72. Taj Pharmaceuticals Recent Developments/Updates
Table 73. Xeris Pharmaceuticals Corporation Information
Table 74. Xeris Pharmaceuticals Description and Business Overview
Table 75. Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Xeris Pharmaceuticals Glucagon Product
Table 77. Xeris Pharmaceuticals Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Glucagon Distributors List
Table 81. Glucagon Customers List
Table 82. Glucagon Market Trends
Table 83. Glucagon Growth Drivers
Table 84. Glucagon Market Challenges
Table 85. Glucagon Market Restraints
Table 86. Global Glucagon Sales Forecast by Type (2022-2029) & (K MT)
Table 87. Global Glucagon Sales Market Share Forecast by Type (2022-2029)
Table 88. Global Glucagon Revenue Forecast by Type (2022-2029) & (US$ Million)
Table 89. Global Glucagon Revenue Market Share Forecast by Type (2022-2029)
Table 90. Global Glucagon Sales Forecast by Application (2022-2029) & (K MT)
Table 91. Global Glucagon Sales Market Share Forecast by Application (2022-2029)
Table 92. Global Glucagon Revenue Forecast by Application (2022-2029) & (US$ Million)
Table 93. Global Glucagon Revenue Market Share Forecast by Application (2022-2029)
Table 94. Global Glucagon Sales Forecast by Region (2022-2029) & (K MT)
Table 95. Global Glucagon Sales Market Share Forecast by Region (2022-2029)
Table 96. Global Glucagon Revenue Forecast by Region (2022-2029) & (US$ Million)
Table 97. Global Glucagon Revenue Market Share Forecast by Region (2022-2029)
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Glucagon
Figure 2. Global Glucagon Market Share by Type in 2020 & 2029
Figure 3. Inject Glucagon Product Picture
Figure 4. Nasal Glucagon Product Picture
Figure 5. Global Glucagon Market Share by Application in 2020 & 2029
Figure 6. Emergency Kits
Figure 7. General Use
Figure 8. Diagnostic & Motility
Figure 9. Cardiogenic Shock
Figure 10. Others
Figure 11. Global Glucagon Revenue, (US$ Million), 2016 VS 2021 VS 2029
Figure 12. Global Glucagon Market Size 2016-2029 (US$ Million)
Figure 13. Global Glucagon Sales 2016-2029 (K MT)
Figure 14. Global Glucagon Market Size Market Share by Region: 2016 VS 20210 VS 2029
Figure 15. Glucagon Sales Share by Manufacturers in 2020
Figure 16. Global Glucagon Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Glucagon Players: Market Share by Revenue in 2020
Figure 18. Glucagon Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Glucagon Sales Market Share by Region (2016-2021)
Figure 20. Global Glucagon Sales Market Share by Region in 2020
Figure 21. Global Glucagon Revenue Market Share by Region (2016-2021)
Figure 22. Global Glucagon Revenue Market Share by Region in 2020
Figure 23. U.S. Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. China Taiwan Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Glucagon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Glucagon by Type (2016-2021)
Figure 46. Sales Market Share of Glucagon by Application (2016-2021)
Figure 47. Sales Market Share of Glucagon by Application in 2020
Figure 48. Revenue Share of Glucagon by Application (2016-2021)
Figure 49. Revenue Share of Glucagon by Application in 2020
Figure 50. Manufacturing Cost Structure of Glucagon
Figure 51. Manufacturing Process Analysis of Glucagon
Figure 52. Glucagon Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
